Jalal Khoshnoodi Selected Research

hersintuzumab

1/2018

Hersintuzumab: A novel humanized anti-HER2 monoclonal antibody induces potent tumor growth inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jalal Khoshnoodi Research Topics

Disease

16	Neoplasms (Cancer) 06/2023 - 12/2006
7	Breast Neoplasms (Breast Cancer) 01/2023 - 07/2013
5	Infections 10/2021 - 10/2010
4	Hepatitis B 10/2021 - 09/2013
3	Whooping Cough (Pertussis) 01/2018 - 01/2013
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2013 - 07/2008
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2011 - 01/2007
2	Leukemia 07/2011 - 02/2008
1	Lymphatic Metastasis 01/2023
1	COVID-19 12/2021
1	Chronic Hepatitis B 10/2021
1	Tetanus 03/2020
1	Infertility (Sterility) 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2011
1	Myeloid Leukemia (Leukemia, Myelocytic) 07/2011
1	Atherosclerosis 03/2011
1	Epstein-Barr Virus Infections 09/2010
1	Hemophilia A (Haemophilia) 05/2009
1	Pathologic Processes 01/2007
1	Residual Neoplasm 01/2007
1	Hepatocellular Carcinoma (Hepatoma) 01/2003

Drug/Important Bio-Agent (IBA)

9	AntigensIBA 12/2021 - 01/2007
6	Monoclonal AntibodiesIBA 01/2023 - 07/2013
6	AntibodiesIBA 09/2022 - 05/2009
5	EpitopesIBA 06/2023 - 05/2009
5	Trastuzumab (Herceptin)FDA Link 02/2020 - 07/2013
5	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2018 - 01/2007
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2017 - 10/2010
3	Immunoglobulins (Immunoglobulin)IBA 03/2020 - 10/2016
3	VaccinesIBA 01/2018 - 02/2016
3	Messenger RNA (mRNA)IBA 07/2011 - 02/2008
2	Proteins (Proteins, Gene)FDA Link 06/2023 - 12/2021
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2021
2	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 01/2013
2	human ERBB2 proteinIBA 11/2017 - 09/2017
2	hepatitis B hyperimmune globulinIBA 01/2017 - 10/2016
2	ThymidineIBA 01/2014 - 01/2003
2	Peptides (Polypeptides)IBA 01/2014 - 05/2009
2	EnzymesIBA 10/2010 - 01/2007
1	Tetanus ToxinIBA 06/2023
1	Tumor Biomarkers (Tumor Markers)IBA 01/2023
1	Immunoglobulin G (IgG)IBA 12/2021
1	Immunoglobulin M (IgM)IBA 12/2021
1	LigandsIBA 10/2021
1	Pattern Recognition ReceptorsIBA 10/2021
1	Interleukin-8 (Interleukin 8)IBA 10/2021
1	Poly I-CIBA 10/2021
1	NeurotoxinsIBA 03/2020
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2019
1	CytokinesIBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	hersintuzumabIBA 01/2018
1	Receptor Tyrosine Kinase-like Orphan ReceptorsIBA 01/2018
1	Humanized Monoclonal AntibodiesIBA 01/2018
1	pertuzumabIBA 01/2018
1	Hemagglutinins (Hemagglutinin)IBA 02/2016
1	Virulence Factors (Pathogenicity Factors)IBA 02/2016
1	Surface Antigens (Surface Antigen)IBA 10/2015
1	Neutralizing AntibodiesIBA 10/2015
1	tetanospasmin (tentoxilysin)IBA 01/2014
1	interleukin-21 (interleukin 21)IBA 06/2013
1	Pertussis VaccineIBA 01/2013
1	oxidized low density lipoproteinIBA 03/2011
1	ImmunosorbentsIBA 10/2010
1	CD40 Ligand (CD40L)IBA 09/2010
1	AutoantibodiesIBA 05/2009
1	Factor VIII (Coagulation Factor VIII)IBA 05/2009
1	Phosphotransferases (Kinase)IBA 01/2007
1	tyrosine receptor (receptor, tyrosine)IBA 01/2007
1	Coloring Agents (Dyes)IBA 01/2003
1	Neutral RedIBA 01/2003
1	Trypan Blue FDA Link 01/2003
1	T-2 Toxin (T 2 Toxin)IBA 01/2003

Therapy/Procedure

5	Immunotherapy 08/2018 - 12/2006
4	Therapeutics 10/2021 - 10/2016